(A) ICC in whole-cell voltage-clamp were held at −50 mV and treated with 0 mM [Ca2+]o solution (solution II) containing NPPB (30 μM) and thapsigargin (1 μM) for 10 min to deplete ER Ca2+ and block CaCC. The cells were dialyzed with Cs+-rich solution containing BAPTA (solution VI). Reintroduction of 2 mM [Ca2+]o (solution I) activated inward current (ICRAC). GSK-7975A (10 μM) completely abolished ICRAC. Ramp potentials from −80 to +60 mV were run during the experiment (examples noted by •, •, and •). (B) Responses to ramp potentials in (A) [• (black trace) is 0 mM [Ca2+]o, • (red trace) is after addition of 2 mM [Ca2+]o, and • (green trace) is after addition of GSK-7975A (10 μM)]. (C) Summary of the effects of GSK-7975A on ICRAC. Data are means ± SEM [n = 5 cells for each group; ***P < 0.001 compared to 0 mM [Ca2+]o, ###P < 0.001 compared to 2 mM [Ca2+]o, one-way analysis of variance (ANOVA)].